Request Free Sample
×
Germany Allergy Immunotherapy Market
ID: MRFR/HC/54527-HCR
200 Pages
June 2025
Germany Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) andBy Patient Type (Pediatric, Adult, Geriatric)- Forecast to 2035
Industry Developments
In recent months, the Germany Allergy Immunotherapy Market has seen significant developments, particularly with companies like BioNTech SE and Novartis AG making strides in research and product offerings. In September 2023, Allergopharma GmbH & Co. KG expanded its portfolio with new immunotherapy products aimed at treating food allergies. Additionally, Merck KGaA announced advancements in biologics designed to enhance the efficacy of treatments for allergic diseases in August 2023. The market is also experiencing increased competition, with Stallergenes Greer and GlaxoSmithKline plc significantly investing in Research and Development to innovate their immunotherapy solutions. In terms of mergers, TheraBurst and Rhinopharma are reportedly in talks to consolidate their market positions, with discussions ongoing since October 2023. This consolidation trend reflects a larger movement in the sector to streamline operations and enhance treatment offerings for patients. Furthermore, as of 2022, the market valuation has shown robust growth, attributed to rising allergy incidences and increasing awareness about immunotherapy benefits among patients and healthcare providers in Germany. The focus on tailoring therapies to individual needs has also gained momentum, driving a new wave of product development in the sector.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 266.0(USD Million) |
| MARKET SIZE 2024 | 285.5(USD Million) |
| MARKET SIZE 2035 | 571.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | BioNTech SE, Stallergenes Greer, TheraBurst, Immunovative Therapies Ltd, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Allergy Therapeutics plc, Rhinopharma, Anergis SA, Merck KGaA, Aimmune Therapeutics Inc., Mylan N.V., Allergopharma GmbH & Co. KG, UCB S.A. |
| SEGMENTS COVERED | Type, Product, Indication, Patient Type |
| KEY MARKET OPPORTUNITIES | Rising prevalence of allergic diseases, Increased investment in research, Growth of personalized medicine approaches, Advancements in delivery technologies, Expanding telehealth services for patients |
| KEY MARKET DYNAMICS | Increasing allergy prevalence, Advancements in immunotherapy, Growing awareness and education, Regulatory support and approvals, Rise in personalized medicine |
| COUNTRIES COVERED | Germany |
FAQs
What is the expected market size of the Germany Allergy Immunotherapy Market in 2024?
The Germany Allergy Immunotherapy Market is expected to be valued at 285.5 million USD in 2024.
What will the market size of the Germany Allergy Immunotherapy Market be by 2035?
By 2035, the market size of the Germany Allergy Immunotherapy Market is projected to reach 571.0 million USD.
What is the expected compound annual growth rate (CAGR) for the Germany Allergy Immunotherapy Market from 2025 to 2035?
The expected CAGR for the Germany Allergy Immunotherapy Market from 2025 to 2035 is 6.504%.
What type of immunotherapy holds the largest market share in Germany?
Subcutaneous Immunotherapy holds the largest market share in Germany, valued at 115.0 million USD in 2024.
What are the future projections for Subcutaneous Immunotherapy by 2035?
By 2035, Subcutaneous Immunotherapy is expected to be valued at 230.0 million USD.
Who are the key players in the Germany Allergy Immunotherapy Market?
Key players in the Germany Allergy Immunotherapy Market include BioNTech SE, Stallergenes Greer, Novartis AG, and GlaxoSmithKline plc.
What will be the market value for Sublingual Immunotherapy in 2024?
Sublingual Immunotherapy is expected to be valued at 85.5 million USD in 2024.
What is the projected market value for Oral Immunotherapy by 2035?
The market value for Oral Immunotherapy is projected to be 170.0 million USD by 2035.
What challenges does the Germany Allergy Immunotherapy Market currently face?
The Germany Allergy Immunotherapy Market faces challenges such as regulatory hurdles and varied patient responses to treatment.
What growth opportunities exist in the Germany Allergy Immunotherapy Market?
Opportunities in the Germany Allergy Immunotherapy Market include advancements in personalized medicine and increasing awareness of allergens.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment